Atenolol Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-D-0006

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Carol Park, Queensland, AUSTRALIA

SourceSAM
Documents3
The Defense Logistics Agency (DLA) Troop Support has issued an award notice for the procurement of Atenolol Tablets, as detailed under contract SPE2D2-25-D-0006. This contract pertains to the ongoing supply of Atenolol Tablets, a pharmaceutical product classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505, which covers drugs and biologicals. The place of performance for this contract is Carol Park, Queensland, Australia (AU-QLD), indicating that manufacturing or distribution activities will be centered in this location. The scope of this procurement encompasses the provision of Atenolol Tablets to meet the requirements of DLA Troop Support, a federal office responsible for supplying medical and pharmaceutical products to U.S. military and associated entities. The contract has been modified to exercise Option Year 1, which will be effective from February 5, 2026, through February 4, 2027. This extension ensures continuity of supply and reflects the agency’s commitment to maintaining a reliable source of essential medications for its stakeholders. Additionally, a previous modification (P00001) was executed in accordance with DoD Class Deviation 2025-O0003, indicating compliance with specific Department of Defense procurement regulations. Key requirements for this contract include adherence to pharmaceutical manufacturing standards as defined by the relevant NAICS and PSC codes, as well as compliance with any applicable DoD deviations or regulatory updates. The expected deliverable is the consistent and timely supply of Atenolol Tablets, meeting quality and safety standards suitable for federal use. The contracting entity, DLA Troop Support, operates as a federal office and can be identified by organization key 500045947. For inquiries or further information, contractors may contact Kyle Lewicki ([email protected], 4457370977) or Jason Wray ([email protected], 4457376304), who serve as the primary and secondary points of contact, respectively. This procurement is classified as an award notice and remains active as of the posting date, June 1, 2026. Interested parties can access additional details and attachments via the official SAM.gov opportunity listing (Opportunity ID: 7bad34ccbd4d49469956d7e942d8a08e). Contractors evaluating this opportunity should note the long-term nature of the contract, the requirement for pharmaceutical manufacturing capabilities, and the need to comply with federal and DoD-specific procurement standards. The place of performance in Australia may also necessitate consideration of international logistics and regulatory compliance. These elements are expected to remain constant throughout the contract lifecycle, ensuring a stable framework for ongoing supply and support.